Library - Page 14 - Scientific articles and publications about the drug Mexidol®.

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Randomized dual-blind, placebo-controlled study of the effectiveness and safety of Mexidol in the complex therapy of ischemic stroke in the acute period

Author:
V. I. SKBORTSOVA, L. V. STAKHOVSKAYA, Y. R. NARCISSOV, M. K. BODYKHOV, I. V. KICHUK, Y. V. GUDKOVA, T. A. SOLDATENKOVA, T. T. KONDRASHOVA, E. V. KALININA, M. A. NOVICHKOVA, O. B. KERBIKOV

Department of Fundamental and Clinical Neurology of the Russian State Medical University, Research Institute of Cytochemistry and Molecular Pharmacology, Moscow

Mexidol in the prevention of intracranial hypertension syndrome with the consequences of closed traumatic brain injury

Authors:
B.M. DORONIN, A.YU. LETYAGIN, O.B. TYSHKEVICH, V.B. DORONIN

Novosibirsk State Medical University, Novosibirsk, 2006

The possibility of using Mexidol in neuropediatrics

Authors:
N.N. ZAVADENKO, N.YU. SUVORINOVA, A.N. ZAVADENKO

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

Registered on ClinicalTrials

N.N. ZAVADENKO¹, N.Yu. SUVORINOVA¹, T.T. BATYSHEVA², O.V. BYKOVA², A.N. PLATONOVA², D.D. GAYNETDINOVA³, E.V. LEVITINA⁴, V.V. MASHIN⁵, I.N. VAKULA⁶, N.E. MAKSIMOVA⁷

¹Pirogov Russian National Research Medical University, Moscow, Russia;
²Scientific and Practical Center for Child Psychoneurology, Moscow Department of Health, Moscow, Russia;
³Kazan State Medical University, Kazan, Russia;
⁴Tyumen State Medical University, Tyumen, Russia;
⁵Ulyanovsk State University, Ulyanovsk, Russia;
⁶Center for Professional Therapy, Krasnodar, Russia.

⁷FSBEI in the Tver State Medical University, Tver, Russia

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2022, Vol. 122, No. 4

Experience in the use of Mexidol® in children and adolescents with mental disorders

Authors:
Yu.Sh. Vasyanina

The use of Mexidol® in children's neurological practice

Authors:
G.R. KHAMITOVA

The use of Mexidol in the correction of vegetative dizregulation syndrome as the consequences of perinatal lesions of the central nervous system

Authors:
M.A. OKUNEVA

The course of school adaptation in children with syndrome of attention deficiency with hyperactivity against the background of the use of Mexidol

Authors:
I.S. POTAPOVA, N.V. KHROMINA, M.V. PROTOPOPOVA

« 1 … 12 13 14